Brief: Tenaya Therapeutics Says Faraz Ali Will Become Interim PFO In Addition To His Role As CEO
08/08/2024 23:30
Aug 8 (Reuters) - Tenaya Therapeutics Inc TNYA.O :
* TENAYA THERAPEUTICS INC - FARAZ ALI WILL BECOME INTERIM
PFO IN
ADDITION TO HIS ROLE AS CHIEF EXECUTIVE OFFICER
* TENAYA THERAPEUTICS INC - LEONE PATTERSON CEASING TO BE
CHIEF
FINANCIAL AND BUSINESS OFFICER, PRINCIPAL FINANCIAL OFFICER FOR
CO
Source text for Eikon: ID:n0000950170-24-093991
Further company coverage: TNYA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tenaya Therapeutics
See all newsBrief: Tenaya Therapeutics Announces Interim Data From Mypeak™-1 Showing Treatment Of Mybpc3-Associated Hcm With TN-201 Gene Therapy Resulted In Consistent Signs Of Cardiac Remodeling And Reductions In Symptoms
Brief: Positive Interim Data From Cohorts 1 And 2 Of Tenaya's Ridge-1 Phase 1B/2 Clinical Trial Of TN-401
Tenaya Therapeutics Q1 net loss widens, misses analyst expectations
Brief: Tenaya Therapeutics Q1 Net Income USD -19.272 Million
Tenaya Therapeutics' Q4 net loss narrows, extends cash runway into H2 2027